Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, announced the agency's approval of COVID boosters for 6-month-olds, citing a trial with just 24 patients.
The U.S. Food & Drug Administration (FDA) is approving booster doses of Pfizer’s COVID-19 shot for children as young as six months based on a trial of just 24 patients.
The FDA announced March 14 that it is amending its emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 v...
